Maintenance Therapy With Subcutaneous Bortezomib

NCT01913730 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

NETWORK

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Bortezomib
DRUG: Dexamethasone

Sponsor

European Myeloma Network B.V.

Collaborators

[object Object]